Join us for an educational webinar on obesity and inflammatory bowel disease (IBD). This session will highlight current evidence on GLP-1 therapies, including clinical considerations and potential anti-inflammatory effects, along with guidance on patient communication and care coordination. Practical topics such as insurance coverage, procedural considerations, and available support resources will also be addressed.
Speakers
Contact
For more information, please contact Kate Carmody, Senior Manager, Professional Education, [email protected].
Sponsors
Special thanks to Eli Lilly for their generous support.
